Stephanie Plaines - 30 Jun 2025 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Issuer symbol
CLX
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 16:28:42 UTC
Previous filing
02 Apr 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plaines Stephanie Director 1221 BROADWAY, OAKLAND By Cheryl Brice, Attorney-in-Fact for 02 Jul 2025 0001771330

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +44 +0.91% $0.000000 4,928 09 May 2025 Common Stock 44 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +219 +4.4% $0.000000 5,146 30 Jun 2025 Common Stock 219 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.